Renal Hyperfiltration in Prediabetes Confirmed by Fasting Plasma Glucose and Hemoglobin A1c

Abstract

Background: The aim of the study was to confirm that glomerular hyperfiltration, an early and reversible stage of kidney damage, is associated in patients with prediabetes and prehypertension. Methods: In total, 5003 people aged between 35 and 69 years who had participated in the Shizuoka part of the Japan Multi-Institutional Collaborative Cohort (J-MICC) study took part in the study. Prevalence of hyperfiltration [the estimated glomerular filtration rate (eGFR) above the age- /sex-specific 95th percentile] was compared among different stages of prediabetes [fasting plasma glucose (FPG) < 100, 100–109, 110–125, and ≥126 mg/dL; and/or hemoglobin A1c (HbA1c) < 5.7, 5.7–6.0, 6.1–6.4 and ≥6.5% for no prediabetes, stage 1 prediabetes, stage 2 prediabetes, and overt diabetes, respectively] and prehypertension (blood pressure <120/80, 120–129/80–84, 130–139/85–89, and ≥140/90 mmHg for no prehypertension, stage 1 prehypertension, stage 2 prehypertension, and overt hypertension, respectively). Results: The prevalence of hyperfiltration increased with increasing stages of prediabetes (odds ratios: 1.25, 1.68, and 2.37 using FPG, and 1.26, 2.15, and 2.45 using HbA1c for stage 1 prediabetes, stage 2 prediabetes, and diabetes, respectively, relative to no prediabetes). Prehypertension, however, was not associated with hyperfiltration. Conclusion: The results confirmed that the prevalence of glomerular hyperfiltration increased with increasing stages (i.e., worsening) of prediabetes. Because both FPG and HbA1c showed similar association with hyperfiltration, either of these can be used to identify subjects who are at increased risk of nephropathy. Therefore, the functioning of kidneys should be monitored in subjects with prediabetes. Prompt treatment of hyperglycemia is necessary in subjects with hyperfiltration to prevent it to cause nephropathy.

• hyperfiltration
• hemoglobin A1c
• impaired fasting glucose
• prediabetes

ACKNOWLEDGMENTS

The authors thank the following members of Seirei Preventive Health Care Center for their support in conducting this study: Hiromi Kaneko, Mika Tanaka, Tamiko Kozu, Akemi Ohnuma, Yoshie Yokoyama, Rie Suzuki, Tomomi Kawashima, Yasuko Nozue, Hisako Haruguchi, Ayako Mizuta, Motomi Ichikawa, Yukie Tsutsui, Erika Murakami, Misao Morishita, Hisae Fukatsu, Ayako Murasato, Yoko Yamashita, Midori Asai, Masami Taira, Miho Takai, Erina Koyama, Yoko Ohta, and Atsushi Koyama. This study was supported in part by a Grant-in-Aid for Scientific Research for Special Priority Areas of Cancer (No. 17015018) and Innovative Areas (No. 22150001) from the Japanese Ministry of Education, Culture, Sports, Science and Technology.

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.